Please provide your email address to receive an email when new articles are posted on . The FDA approved the first and only IV iron replacement therapy indicated for people with heart failure and iron ...
Researchers have observed that the gut microbiota in patients with inflammatory bowel disease are distinctly altered by iron replacement therapy depending on the route of administration. They also ...
Carnexiv, an antiepileptic drug, is a short-term (≤7 days) intravenous (IV) replacement therapy for oral carbamazepine formulations in adults. The Food and Drug Administration (FDA) has approved ...
The FDA has granted Fast Track designation to intravenous choline chloride (Protara Therapeutics), an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results